These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6350023

  • 41. The protective effect of acylation on the stability of anisoylated plasminogen streptokinase activator complex in human plasma.
    Fears R, Ferres H, Standring R.
    Drugs; 1987; 33 Suppl 3():57-63. PubMed ID: 2960514
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [The new thrombolytic agents].
    Bassand JP.
    Ann Cardiol Angeiol (Paris); 1989 Sep 30; 38(7 Pt 2):487-91. PubMed ID: 2511796
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Induction of a sustained fibrinolytic response by BRL 26921 in vitro.
    Fears R, Green J, Smith RA, Walker P.
    Thromb Res; 1985 May 01; 38(3):251-60. PubMed ID: 3895561
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Bossaert LL, Demey HE, Colemont LJ, Beaucourt L, Fierens H, Dirix L, Pintens H.
    Crit Care Med; 1988 Sep 01; 16(9):823-30. PubMed ID: 3042284
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction.
    Kasper W, Erbel R, Meinertz T, Drexler M, Rückel A, Pop T, Prellwitz W, Meyer J.
    J Am Coll Cardiol; 1984 Aug 01; 4(2):357-63. PubMed ID: 6429226
    [Abstract] [Full Text] [Related]

  • 55. A randomised placebo-controlled pilot dose-response study with anisoylated plasminogen streptokinase activator complex in acute coronary artery occlusions.
    Leizorovicz A, Durrieu G, Boissel JP.
    Drugs; 1987 Aug 01; 33 Suppl 3():133-7. PubMed ID: 3315579
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD, Griffin B, Crick JC, Flax JS, Sowton E.
    Drugs; 1987 Aug 01; 33 Suppl 3():146-50. PubMed ID: 3315582
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.